
    
      All subjects will be randomized into two groups. One group will receive DTPw vaccine
      co-administered with Hib and another group will receive DTPw vaccine alone. A specific
      follow-up of solicited local and general symptoms after each vaccination. A specific
      follow-up of unsolicited symptoms after each vaccination. Recording of serious adverse events
      reported during the study period.
    
  